mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.34 |
0.03 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.03 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
Irinotecan |
FIMM |
pan-cancer |
AAC |
0.26 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.098 |
0.04 |